Dr. Nagourney's Blog


Informative articles sent right to your inbox. Subscribe to Dr. Nagourney's blog today.

For Some Cancers Are There Immunotherapy Hazards?
By Robert A. Nagourney, MD
A report by French investigators has raised concern regarding the broad application of immunotherapy in lung cancer. Checkpoint inhibitors like ipilimumab, pembrolizumab and nivolumab have gained traction in oncology as patients with advanced...
Cancer Immunotherapy Suffers A Setback: Cause For Alarm?
By Robert A. Nagourney, MD
Cancer immunotherapy, which uses the patient's immune system to eradicate disease, has been the subject of investigation for...

most popular articles

patient story

How We Helped David Hanbidge

"I'll never forget the day when the doctor took my wife and me to a small back office and told us the horrible news…I had the very worst kind of lung cancer..."   Read about how we helped David.